Clinical Trial Update: Intensity Modulated Radiation Therapy (IMRT) Pelvic Nodes Prostate [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates report on intensity modulated radiation therapy (IMRT) to pelvic nodes for prostate cancer, spanning Phase 1 and Phase 2, and completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Prostate

Drugs mentioned

• Intensity Modulated Radiation Therapy (IMRT) for pelvic nodes

Snippet

Sponsor: University Health Network, Toronto | Conditions: Adenocarcinoma of the Prostate | Phase 1, Phase 2 | Status: COMPLETED